Showing results for "X4 Pharmaceuticals"
markets
S&P 500 Companies Adjust GAAP Net Income for More Items, Boost EPSLarge US companies are bolstering their adjusted earnings per share by excluding items such as litigation expenses and amortization of intangible assets from their net income, even as regulators scrutinize such practices, a new analysis finds.May 22, 2024
business
Financial Sponsors Begin to Drive Deals as Asia Looks to Catch UpHi, it’s Dong Cao and Manuel Baigorri in Hong Kong. We spoke with a senior investment banker at Bank of America on sentiment around private equity deals in the Asia-Pacific region. Also today, Anglo rejects new BHP offer and Chelsea considers sale of stake in women’s team. Today's top storiesMay 13, 2024